Rejuvesol
Active substance: SODIUM PYRUVATE, INOSINE, ADENINE, SODIUM PHOSPHATE, DIBASIC, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
SOLUTION · SODIUM PYRUVATE .55 g/50mL, INOSINE 1.34 g/50mL, ADENINE .034 g/50mL, SODIUM PHOSPHATE, DIBASIC .73 g/50mL, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .311 g/50mL
United StatesActive
Marketing holder: Citra Labs, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM PYRUVATE · .55 g/50mL
- INOSINE · 1.34 g/50mL
- ADENINE · .034 g/50mL
- SODIUM PHOSPHATE, DIBASIC · .73 g/50mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · .311 g/50mL
Registration
- Registration number
- 23731-7000
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- EXTRACORPOREAL
Sources
- product · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 23731-7000 · Verified 2026-10-09 · open in source